Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data

Piyanuch Kongtim, Andrew Portuguese, Soyoung Kim, Andrew Peterson, Hany Elmariah, Lori Muffly, Mark Juckett, Michael Grunwald, Mariam Nawas, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Xia Bi, Ryan Stubbins, Wael Saber, Stefan Ciurea, Bart Scott

Blood (2025) 146 (Supplement 1): 109.

https://doi.org/10.1182/blood-2025-109

Published: 2025

Journal Articles

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Monzr M. Al Malki, Corey Cutler, Ronald Sobecks, Iskra Pusic, Nelli Bejanyan, Sagar Patel, Arpita Gandhi, Vamsi Kota, Nabeel Rajeh, Piyanuch Kongtim, Chun-Po Fan, Yangyang Hao, Evgeniya Vaskova, Natali Gulbahce, Ashish Kothari, Nishant Dwivedi, Robert Woodward, Ran Reshef, Stefan Ciurea

Blood (2025) 146 (Supplement 1): 4301.

https://doi.org/10.1182/blood-2025-4301

Published: 2025

Journal Articles

Daunorubicin and cytarabine liposomal (CPX-351) plus glasdegib for newly diagnosed secondary Acute Myeloid Leukemia: Results of University of California hematologic malignancies consortium trial 1913

Deepa Jeyakumar, An To, Piyanuch Kongtim, Kiran Naqvi, Pamela Becker, Brian Jonas, Caspian Oliai, Gary Schiller, Matthew Wieduwilt, Lloyd Damon

Blood (2025) 146 (Supplement 1): 5241.

https://doi.org/10.1182/blood-2025-5241

Published: 2025

Journal Articles

Blinatumomab before and after allogeneic hematopoietic stem cell transplantation in adult patients with B-cell acute lymphoblastic leukemia

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Kiran Naqvi, Benjamin Lee, Jean Doh, Shawn Griffin, Jeffrey Kuo, Jeremy Harris, Piyanuch Kongtim, Stefan Ciurea

Blood (2025) 146 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2025-2520

Published: 2025

Journal Articles

Comparative outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis

Chalothorn Wannaphut, Piyatida Chumnumsiriwath, Stefan Ciurea, Piyanuch Kongtim

Blood (2025) 146 (Supplement 1): 2425.

https://doi.org/10.1182/blood-2025-2425

Published: 2025

Journal Articles

Final Results of a Prospective Observational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation

Piyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin Lee, Jean Doh, Shawn P. Griffin, Richard Van Etten, Stefan O. Ciurea

Blood (2024) 144 (Supplement 1): 4908.

https://doi.org/10.1182/blood-2024-202468

Published: 2024

Journal Articles

Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Kiran Naqvi, Benjamin Lee, Jean Doh, Shawn P. Griffin, Jeffrey Kuo, Jeremy Harris, Piyanuch Kongtim, Stefan O. Ciurea

Blood (2024) 144 (Supplement 1): 7307.

https://doi.org/10.1182/blood-2024-201752

Published: 2024

Journal Articles

Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia

Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Piyanuch Kongtim, Deepa Jeyakumar, Kiran Naqvi

Blood (2024) 144 (Supplement 1): 1517.

https://doi.org/10.1182/blood-2024-202856

Published: 2024

Journal Articles

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin J. Lee, Jean Doh, Shawn Griffin, Richard A. Van Etten, Piyanuch Kongtim, Stefan Ciurea

Blood (2023) 142 (Supplement 1): 2192.

https://doi.org/10.1182/blood-2023-190530

Published: 2023

Journal Articles

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Eli M Soyfer, Jane H Chen, Piyanuch Kongtim, Angela G. Fleischman

Blood (2023) 142 (Supplement 1): 6443.

https://doi.org/10.1182/blood-2023-187912

Published: 2023

Journal Articles

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Ashish S Kothari, Nishant Dwivedi, Camila Egidio, Mingwei Fei, Allison Bell, Piyanuch Kongtim, Marica Grskovic, Stefan Ciurea

Blood (2022) 140 (Supplement 1): 13005–13006.

https://doi.org/10.1182/blood-2022-170443

Published: 2022

Journal Articles

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Piyanuch Kongtim, Mary-Elizabeth M. Percival, Timothy J Martins, Guangrong Qin, Niall Curley, Kelda M. Gardner, Sylvia Chien, Jin Dai, Vivian G. Oehler, C. Anthony Blau, Paul C. Hendrie, Ryan D. Cassaday, Anna B. Halpern, Bart L. Scott, Roland B. Walter, Heather Smith, Guido Marcucci, Pamela S. Becker

Blood (2022) 140 (Supplement 1): 1200–1202.

https://doi.org/10.1182/blood-2022-165801

Published: 2022

Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-134858

Published: 2020

Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin

Blood (2020) 135 (6): 449–452.

https://doi.org/10.1182/blood.2019003662

Published: 2020

Includes: Supplemental data

Journal Articles

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Piyanuch Kongtim, MD, Kotchanut Litlueangdet, Darunee Emrat, MD BSc, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Wasithep Limvorapitak, MD, Nonglak Kanitsap, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2019) 134 (Supplement_1): 2421.

https://doi.org/10.1182/blood-2019-123682

Published: 2019

Journal Articles

Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis

Stefan O. Ciurea, MD, Ankur Varma, MD, Piyanuch Kongtim, MD, Samer Srour, Qaiser Bashir, MBBS, Amin M. Alousi, MD, Rohtesh S. Mehta, MD, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, MD, Gabriela Rondon, MD, Julianne Chen, Amanda L. Olson, MD, Marina Y Konopleva, MD PhD, Richard E Champlin

Blood (2019) 134 (Supplement_1): 42.

https://doi.org/10.1182/blood-2019-123699

Published: 2019

Journal Articles

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Jorge M. Ramos Perez, MD, Gabriela Rondon, MD, Julianne Chen, Abhishek R Chilkulwar, Gheath Alatrash, DO, PhD, Amin M. Alousi, MD, Borje S Andersson, MD PhD, Jin S Im, MD PhD, Chitra Hosing, MD, Qaiser Bashir, MD MBBS, Issa F. Khouri, Partow Kebriaei, MD, Betul Oran, MD MS, Uday Popat, MD, Richard E Champlin, MD, Stefan O. Ciurea

Blood (2018) 132 (Supplement 1): 2141.

https://doi.org/10.1182/blood-2018-99-111639

Published: 2018

Journal Articles

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Blood (2018) 132 (Supplement 1): 3450.

https://doi.org/10.1182/blood-2018-99-111606

Published: 2018

Journal Articles

Incidence, Characteristics and Outcomes of Patients with Cancer-Associated Venous Thromboembolism: A Retrospective Matched-Pair Analysis

Piyanuch Kongtim, MD, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2018) 132 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2018-99-113420

Published: 2018

Journal Articles

Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Gabriela Rondon, MD, Julianne Chen, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, Qaiser Bashir, MD MBBS, Partow Kebriaei, MD, Issa F. Khouri, Richard E. Champlin, MD, Stefan O. Ciurea

Blood (2017) 130 (Supplement 1): 4511.

https://doi.org/10.1182/blood.V130.Suppl_1.4511.4511

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Daunorubicin and cytarabine liposomal (CPX-351) plus glasdegib for newly diagnosed secondary Acute Myeloid Leukemia: Results of University of California hematologic malignancies consortium trial 1913

Blinatumomab before and after allogeneic hematopoietic stem cell transplantation in adult patients with B-cell acute lymphoblastic leukemia

Comparative outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis

Final Results of a Prospective Observational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation

Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation

Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Incidence, Characteristics and Outcomes of Patients with Cancer-Associated Venous Thromboembolism: A Retrospective Matched-Pair Analysis

Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only